All Type of News
Kunwha Pharmaceutical, The stock price drops to the lowest limit due to recapitalization to raise funds to take over Dream Pharma
Kunwha Pharmaceutical posted a notice of KRW 134.345 billion worth of recapitalization to raise funds to take over 100% shares of the drug manufacturing corporation divided from Dream Pharma.
The number of the newly ...
The marginal structure with high pharmaceutical distribution margin, worth of KRW 2.6 trillion
Congressman Yong-ik Kim from the New Politics Alliance for Democracy pointed out the need for revised pharmaceutical distribution structure as the margin rate of domestic pharmaceutical wholesalers has exceeded KRW 2....
‘Rushes’ of domestic pharmaceutical companies into clinical studies for global new drugs
As domestic pharmaceutical companies have enlarged the possibility of overseas expansion through their self-developed new drugs, it was noticed that the new drugs has passed clinical trials in the U.S. market, the big...
“A new obesity drug will be used in Korea”
The expectation of the medical industry towards new obesity drugs are growing.
Discussions about ‘The Future Direction of Obesity Medication’ was made at the 41st Autumn Academic Conference in 2014 held by the Korean...
What is the possibility for the maximum volume of acetaminophen to be changed?
The request of acetaminophen volume reduction, which has been brought up several years, has continued this year again.
To reduce the maximum dose per a time and the maximum volume per a day is the gist.
In order to ...
‘Viread’ will be recommended for most hepatitis B MDR patients
A domestic guideline that recommends exclusive prescription of ‘Viread’ to hepatitis B MDR (multiple drug resistance) patients will be introduced.
The Korean Association for the Study of the Liver (KASL) announced to...
Sun-hye Jo, CEO of Geo-Young, stated “The value of the pharmaceutical distribution industry has been underrated”Sun-hye Jo, chief vice president of the Korea Pharmaceutical Distribution Association (president, Geo-Young) made a speech as the representative of Korea at the session ‘Korea-C...
|
Caught between ‘rebate’ and ‘ethical management’… the suggested solution is a CEO’s will
As controversy, such as the K hospital, about the rebate system in the pharmaceutical industry has recently risen again, it was noticed that a meaningful time and place for the spread of ethical management was arrange...
A series of pharmaceutical companies’ lawsuits… Is it considered as an improper group action?
Recently, domestic pharmaceutical companies in Korea are fearlessly(?) facing lawsuits against the government regarding insurance expenses. They tried to resist against the Ministry of Health and Welfare’s ‘drug price...
Pfizer has the most products in the list of the top 30 outpatient prescriptions
The pharmaceutical company with the most sales product in the collective outpatient prescription market on the third quarter of the year was, of course, Pfizer.
The current circumstance in the pharmaceutical industry...
